reference/7216960

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7216960

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	3572
issn	1527-7755 0732-183X
issueIdentifier	21
pageRange	3567-3572
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	3567
bibliographicCitation	Simon GR, Verschraegen CF, Jänne PA, Langer CJ, Dowlati A, Gadgeel SM, Kelly K, Kalemkerian GP, Traynor AM, Peng G, Gill J, Obasaju CK, Kindler HL. Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial. J Clin Oncol. 2008 Jul 20;26(21):3567–72. doi: 10.1200/jco.2007.15.2868. PMID: 18640937.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eb1ac898e4a0c4ed6f54060f3562c90e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d436714a0168b28418c18ea736c30e5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_372ece35ea14fdd5bbd501acef80add5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_092fc7e1b07ab4864703e168c51299ef http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_75cab7ce87cd9657df180fc083f1f1d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1f4f1b93b4e7a06de41ac12941566728 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd93cb342fad65e41dd7f13c5962f2bb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_146a2b3d359a0dfeb259c8abb22ab02d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a68371cca1be251830b8465ed59ca456 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b66029ff00fb9fdb6191ec754db7eec3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7db666e3f32932c6c054d080a7730b32 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2024c5b9609dd8d6491986edcc11c6a0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f62a3e679d194bf4e6edf17d49890f77
date	2008-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/18640937 https://doi.org/10.1200/jco.2007.15.2868
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023 https://portal.issn.org/resource/ISSN/1527-7755 https://portal.issn.org/resource/ISSN/0732-183X
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Pemetrexed Plus Gemcitabine As First-Line Chemotherapy for Patients With Peritoneal Mesothelioma: Final Report of a Phase II Trial
discusses	http://id.nlm.nih.gov/mesh/M0009679 http://id.nlm.nih.gov/mesh/M000754277 http://id.nlm.nih.gov/mesh/M0227083 http://id.nlm.nih.gov/mesh/M0009376 http://id.nlm.nih.gov/mesh/M0005997
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D010997Q000188 http://id.nlm.nih.gov/mesh/D008654Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006147Q000008 http://id.nlm.nih.gov/mesh/D008654Q000401 http://id.nlm.nih.gov/mesh/D005971Q000008 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000068437 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D006147Q000009 http://id.nlm.nih.gov/mesh/D005971Q000009 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D003841Q000031 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000093542 http://id.nlm.nih.gov/mesh/D053208 http://id.nlm.nih.gov/mesh/D003841Q000008 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D006147Q000031 http://id.nlm.nih.gov/mesh/D010997Q000401 http://id.nlm.nih.gov/mesh/D003841Q000009
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7172 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11445 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID936 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7333 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398658 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8482

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127639621 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129439837 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128866026

Total number of triples: 79.